Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

android tablet pc

Home > Press > Stop Press: Nanosight Shortlisted For Award In The Emerging & Nanotechnology Category

NanoSight’s founder and CTO, Dr Bob Carr
NanoSight’s founder and CTO, Dr Bob Carr

Nanosight announces CTO Bob Carr to speak about Novel Biomarkers for Early Disease Detection and Treatment

Stop Press: Nanosight Shortlisted For Award In The Emerging & Nanotechnology Category

Salisbury, UK | Posted on November 11th, 2010

NanoSight, world-leading manufacturers of unique nanoparticle characterization technology announce their founder and CTO, Dr Bob Carr, will be speaking at the 2010 Technology World/NanoForum event at London's ExCeL centre on December 7th. This meeting annually showcases UK science & technology and this is the third year when NanoSight will give a mainstream presentation in the event which attracts more than 2,000 visitors from all around the world over the two day meeting. Dr Carr will discuss the potential of nanotechnology for early disease detection.

The condition pre-eclampsia in pregnant women remains a prominent cause of maternal and perinatal death. Pre-eclampsia is symptomless for most of its course and it is relentlessly progressive. No other complication of pregnancy is so common and so dangerous for both mother and baby.

Exosomes are 30nm - 100nm vesicles formed in blood as they shed from cells. Known to have key roles in intercellular communication, exosomes are promising biomarkers for early detection of pre-eclampsia. To date developments in this area have been constrained by limitations in the technology available for measurement of exosomes. Electron microscopy, western blotting, enzyme-linked immunosorbent assays and conventional flow cytometry all have weaknesses in detection and characterisation of exosomes.

Working with researchers at Oxford Radcliffe Hospitals/University of Oxford, NanoSight has developed unique technology which can for the first time detect and phenotype exosomes.

Starting in 2005, NanoSight developed a method of laser illumination which enables detection and counting of populations of nanoparticles in real time and with little sample preparation. This method, Nanoparticle Tracking Analysis (NTA), simultaneously measures sizes of many particles on a particle-by-particle basis to give a uniquely detailed particle size distribution. Supported by a grant from The Wellcome Trust, the teams have combined fluorescent labeling with NTA to produce a capability to speciate these exosomes. This development effectively extends the power of flow cytometry downwards by one nearly one order of magnitude to the 50-600nm size range, and will perhaps provide early detection of a range of thrombosis-related disease.

To learn more about nanoparticle characterization using Nanoparticle Tracking Analysis, NTA, please visit the company website ( and register for the latest issue of NanoTrail, the company's electronic newsletter.

To register and listen to Bob Carr's talk at Technology World 2010, please visit


About Nanosight
NanoSight Limited, of Salisbury, UK, provides unique nanoparticle characterization technology. “Nanoparticle Tracking Analysis” (NTA) detects and visualizes populations of nanoparticles in liquids down to 10nm (material dependent) and measures the size of each particle from direct observations of diffusion. This particle-by-particle methodology goes beyond traditional light scattering techniques such as Dynamic Light Scattering (DLS), or Photon Correlation Spectroscopy (PCS), in providing high-resolution particle size distributions. Fluorescence options add a speciation capability. Additionally NanoSight measures concentration/titer and validates all data with video of particles moving under Brownian motion.

This characterization information is highly informative for the more complex suspensions in biological systems, hence its wide application in development of drug delivery systems, protein aggregation study, viral vaccines, the study of toxicology of nanoparticles and their environmental fate and in biomarker detection. This real-time data also provides insight into the kinetics of protein aggregation and other time-dependent phenomena in a quantitative manner, at deeply sub-micron sizes.

NanoSight has more than 250 systems installed worldwide with users including BASF, GlaxoSmithKline, Merck, Novartis, Roche, Solvay and Unilever together with many universities and research institutes. There are currently approaching 150 third party papers citing NanoSight results, having added 50 in the last 12 months, as NanoSight consolidates its key contribution to nanoparticle characterization. For more information, visit the NanoSight website (

For more information, please click here

NanoSight Limited
Minton Park
London Road
Amesbury SP4 7RT
T +44 (0) 1980 676060

NetDyaLog Limited
39 de Bohun Court
Saffron Walden
Essex CB10 2BA
T +44 (0) 1799 521881

Copyright © Nanosight

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

East China University of Science and Technology Purchases Nanonex Advanced Nanoimprint Tool NX-B200 July 30th, 2014

Watching Schrödinger's cat die (or come to life): Steering quantum evolution & using probes to conduct continuous error correction in quantum computers July 30th, 2014

From Narrow to Broad July 30th, 2014

FLAG-ERA and TNT2014 join efforts: Graphene Networking at its higher level in Barcelona: Encourage the participation in a joint transnational call July 30th, 2014


New imaging agent provides better picture of the gut July 30th, 2014

Zenosense, Inc. July 29th, 2014

Optimum inertial design for self-propulsion: A new study investigates the effects of small but finite inertia on the propulsion of micro and nano-scale swimming machines July 29th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014


University of Manchester selects Anasys AFM-IR for coatings and corrosion research July 30th, 2014

Nature inspires a greener way to make colorful plastics July 30th, 2014

Analytical solutions from Malvern Instruments support University of Wisconsin-Milwaukee researchers in understanding environmental effects of nanomaterials July 30th, 2014

FEI Unveils New Solutions for Faster Time-to-Analysis in Metals Research July 30th, 2014


New imaging agent provides better picture of the gut July 25th, 2014

Hysitron is Awarded TWO R&D 100 Awards for Highly Innovative Technology Developments in the Areas of Extreme Environments and Biological Mechanical Property Testing July 23rd, 2014

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

EPFL Research on the use of AFM based nanoscale IR spectroscopy for the study of single amyloid molecules wins poster competition at Swiss Physics Society meeting July 22nd, 2014


Harris & Harris Group Invests in Unique NYC Biotech Accelerator July 29th, 2014

Seeing is bead-lieving: Rice University scientists create model 'bead-spring' chains with tunable properties July 28th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

Scientists Test Nanoparticle "Alarm Clock" to Awaken Immune Systems Put to Sleep by Cancer July 25th, 2014

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE